Govt to set up 3 bulk drug parks to make APIs for medicine
"It is high time we produce also the chemicals and other raw materials used in making live-saving drugs rather than depend on China," said Gowda in a statement here.
Bengaluru: The Central government would set up 3 bulk drug parks to make chemicals compounds or active pharmaceutical ingredients (APIs) for medicines and reduce their imports from China, said Union Minister for Chemicals and Fertilisers D.V. Sadananda Gowda on Friday.
"The bulk drugs parks will be set up at a cost of Rs 14,300 crore in partnership with states to make chemicals for live-saving drugs and reduce their imports from China," said Gowda in a statement on the occasion of New Year here.
Though India is the biggest exporter of medicines to the world, China is the main supplier of chemicals (APIs) used in making drugs.
"It is high time we produce also the chemicals and other raw materials used in making live-saving drugs rather than depend on China," said Gowda in a statement here.
The ministry plans to also set up 4 additional parks to make a range of medical devices as an import-substitute under the Union government's Atmanirbhar Bharat flagship programme in the pharma sector.
The Union Cabinet on March 20, 2020 approved the schemes to set up 3 bulk drug parks to make APIs and intermediates over the next 5 years.
The ministry also issued guidelines on July 27 for setting up the parks for making ingredients and medical devices.
Besides Karnataka, Andhra Pradesh and Himachal Pradesh are among 14 states in race to set up the parks by offering land, other facilities and incentives.
To be self-sufficient in fertilisers for increasing food production, the Centre is setting up 5 urea plants with 12-lakh tonne capacity each per year across the country at an estimated cost of Rs 50,000 crore.
"One urea plant is getting ready at Ramagundam in Telangana for commencing production soon," said Gowda.
Though the country was dependent on imports of personal protection equipment (PPE) kits and ventilators to fight coronavirus since the pandemic broke in March last year, the industry ramped up their production to 4 lakh PPEs per day.
"Amid the Covid crisis, India exported live-saving drugs to about 120 countries the world over after meeting our needs. Even the World Health Organisation (WHO) has appreciated our country's contribution in the fight against the virus," added Gowda.
Read also: Govt says PLI schemes for bulk drugs, medical devices get encouraging response
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.